A carregar...
PBRM1 mutation and preliminary response to immune checkpoint blockade treatment in non-small cell lung cancer
Polybromo-1 (PBRM1) gene is a promising biomarker for immunotherapy in clear cell renal cell carcinoma. But to our knowledge, the frequency and clinical relevance of PBRM1 mutation in lung cancer remain unknown. We conducted a retrospective study to evaluate the prevalence of PBRM1 mutation and its...
Na minha lista:
| Publicado no: | NPJ Precis Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group UK
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7075870/ https://ncbi.nlm.nih.gov/pubmed/32195359 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41698-020-0112-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|